Oak Grove Capital’s Prothena Corp PRTA Stock Holding History

Oak Grove Capital’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2	Closed	–	–	134
2018 Q3	$0	Hold	2	–	–	﹤0.01%	173
2018 Q2	$0	Hold	2	–	–	﹤0.01%	177
2018 Q1	$0	Buy	+2	New	+$73	﹤0.01%	176

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Oak Grove Capital's PRTA Position: Q4 2018 in Review

Oak Grove Capital sold out of Prothena Corp (PRTA) in Q4 2018, closing a stake of 2 shares.

Oak Grove Capital first reported a position in PRTA in Q1 2018 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 120 funds tracked by Wall St. Rank hold PRTA as of Q4 2018.

Oak Grove Capital reported no remaining Prothena Corp position as of Q4 2018 after selling out during the quarter.
Oak Grove Capital sold 2 Prothena Corp shares in Q4 2018.
Oak Grove Capital first reported a position in Prothena Corp in Q1 2018 and held it in 3 quarters.
Oak Grove Capital's Prothena Corp position peaked at $0 in Q3 2018.
120 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2018.

Based on Oak Grove Capital's 13F filing for Q4 2018, filed 15 Feb 2019.